Real-time enrollment status for this allogeneic stem cell transplant clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:13 PM UTC
| NCT Number | NCT06784336 |
| Recruiting Status | Recruiting |
| Condition | Allogeneic Stem Cell Transplant |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | November 28, 2025 (Nov 28, 2025) |
As of July 17, 2026: Clinical trial NCT06784336 is currently recruiting participants. This phase2 study for allogeneic stem cell transplant is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06784336 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06784336 was last updated Nov 28, 2025 (November 28, 2025). HelloStudys verifies this status automatically.